A-IMAGIO: Prospective Cohort Study on Thermal Ablation of Malignant Liver Tumors Within the IMAGIO Project
Principal Investigator: Dott. Lanocita Rodolfo
Main Facility: Radiologia diagnostica ed Interventistica
Drug: Thermal ablation devices (radiofrequency or microwave ablation probes)
Pathologies: Hepatocellular carcinoma (HCC)
ClinicalTrials.gov: Read more about clinical trials
A-IMAGIO is a prospective cohort study designed to evaluate the safety and efficacy of thermal ablation techniques (such as radiofrequency ablation or microwave ablation) for the treatment of malignant liver tumors.
The study is part of the broader IMAGIO project and aims to collect real-world, systematic data on clinical outcomes, procedural success, local tumor control, recurrence rates, and safety in patients undergoing thermal ablation. Both primary and secondary liver malignancies may be included, with emphasis on optimizing patient selection, technique standardization, and follow-up strategies.
Last update: 20/04/2026